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Kuehni and Spycher have provided a timely discussion
about the association between ionising radiation from nuc-
lear power plants (NPPs) and leukaemia in children [1].
Whereas some studies observed such associations, others
were unable to refute the null hypothesis of no effect. This
was also encountered in the census- and registry-based
Swiss CANUPIS study [2]. The inability to refute the null
hypothesis is, of course, not proof of the null hypothes-
is and – as mentioned by Kuehni and Spycher – scient-
ists agree that ionising radiation causes cancer with no
“threshold of no effect”. Thus, the question is why the
plausible hypothesis of a carcinogenic effect of NPP-re-
lated radiation remains unproven.
Observing and, thus, quantifying those effects in humans
under real-life conditions poses a major scientific chal-
lenge. Exposure differences between those living close to
a NPP and the rest of the population are, under normal op-
eration, very small. Thus, the methodological challenge is
comparable to a hypothetical study about the health effects
of smoking assuming only two study groups, namely one
smoking three cigarettes and one smoking four cigarettes
per day. This setting would jeopardise the ability to estab-
lish the well-known dose-response without threshold un-
less the study populations were extremely large. Related
to NPPs, all one can conclude at this stage is the cautious
statement that if NPP-related radiation causes early-life
leukaemia, the excess risk among the exposed as compared
with the not exposed may be relatively small and the pro-
portion of cases attributable to NPPs is expected to be small
too as long as only a minor fraction of the population is liv-
ing close to NPPs.
Interestingly, despite several decades of research, the aeti-
ology of childhood leukaemia remains in general rather un-
clear and the short list of established causes may explain
only some 10% of all cases [3]. Inconsistent findings may
not only indicate that the relative risks are most likely not
very large across the range of exposure, but also point
toward complex aetiological pathways and interactions
among a range of factors and mechanisms – a phenomenon
very well known in chronic disease epidemiology [4]. To
detect relatively small effects at low levels and across small
differences in exposure, and to separate those effects from
the role of other cofactors, is a challenge. Although epi-
demiology is the key science to enlighten the complex
“web of causation”, epidemiologists cannot guarantee to
achieve this goal; thus, Kuehni and Spycher are right to
call for further and better research to investigate properly
the role of low-level ionising radiation on childhood can-
cer. Though I agree with their general suggestions, a few
issues may need some further specification.
The role of meta-analyses is well emphasised. Meta-ana-
lyses should, though, exclude purely ecological analyses
– studies that only provide correlations across aggregated
data. There is clear methodological proof and applied evid-
ence showing that correlations in aggregate data cannot re-
liably estimate individual-level associations [5]. It is not
only impossible to control individual-level confounders in
ecological analyses, but it is of particular concern that one
cannot predict the direction of the biases possibly present
in the ecological correlations, nor properly analyse interac-
tions or adjust for confounders in any reliable way [6–8].
A scholarly literature in the field of ionising radiation due
to natural radon and lung cancer underscores how ecolo-
gical correlations may mislead in indicating “protective ef-
fects” of radon at low doses [9]. Although this was ob-
served in several ecological analyses, prospective cohort
data have clearly disqualified those findings with analyses
based on individual data [10, 11]. A simulation of Brenner
et al. illustrated the very serious unpredictability of the bias
in ecological associations between the community-level
prevalence of smoking and lung cancer mortality rates.
Depending on the (by default unknown) specificity and
sensitivity of the aggregated exposure data, the ecological
associations may indicate smoking to be protective against
lung cancer [12].
The best meta-analytic estimate is one based solely on aeti-
ologically sound research with individual-level data avail-
able on the outcome, the exposure to radiation, as well
as on all relevant covariates. In light of the highly mul-
tifactorial nature, the list of individual level covariates
should not be too short but include at least all factors and
exposures possibly related to leukaemia, such as tobacco
smoke, benzene and other air pollutants, solvents and other
chemicals, ionising and nonionising radiation, pesticides,
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immunological and dietary factors, markers of genetic sus-
ceptibility and socioeconomic conditions [3]. One should
have information about these factors both during preg-
nancy and in early life. The well-done Swiss CANUPIS
study discussed by Kuehni and Spycher provides an ex-
ample of the challenges faced with individual-level re-
gistry- and census-based data where none of these covari-
ates may be available on the individual level. It is very
unlikely, that one will conclusively unravel the NPP-leuk-
aemia hypothesis with studies with a similar lack of
individual-level data.
My conclusion is that we must clearly go beyond registry-
and census-based research to promote conclusive know-
ledge in the fields of complex multifactorial diseases.
Without large-scale prospective studies with individual-
level information about phenotypes, and functional, struc-
tural and biological data complemented with solid data
about all other aetiologically essential dimensions of health
(social, environmental, cultural), the complex “web of
causation” of health and disease will not be uncovered. We
need to call for a very large, prospective long-term study
platform – namely a Swiss mega-cohort, including not only
patients but also subjects from the general population. Such
a mega-cohort with its inherent biobank needs to include
not tens but hundreds of thousands of subjects from all
sociocultural backgrounds, to be followed up for decades.
Switzerland with its 7 million inhabitants and a highly
successful record in research cannot leave such life sci-
ence platform initiatives to other countries such as Sweden,
the United Kingdom, Germany and many others, where
cohorts (with biobanks) of several 100,000 subjects are
already established or initiated (see, e.g., the pan-European
Biobanking and Biomolecular Resources Research Infra-
structure (BBMRI) – http://bbmri-eric.eu/ [13].
Indeed, promising steps have been taken in recent years, in-
cluding the Swiss National Science Foundation (SNF) in-
vestment into smaller cohort studies and its most recent de-
cision to invest in a Swiss biobank platform, where the two
pillars of patient-based (led by Vincent Mooser, Lausanne)
and population-based cohorts (Nicole Probst-Hensch,
SwissTPH Basel) lay essential ground for the journey to-
ward a Swiss mega-cohort [14]. It is crucial that all stake-
holders – including the Federal and Cantonal agencies –
continue to pull in the same direction to establish a well-
standardized national mega-cohort, targeted to the research
needs of the Swiss healthcare system, personalised medi-
cine as well as personalised prevention and health promo-
tion [14].
Kuehni and Spycher are right that prospective cohorts will
be inefficient to investigate the NPP-leukaemia hypothesis
given the low incidence [1]. However, this research – like
almost any other health-relevant research – will greatly
profit from a large-scale prospective population-based
mega-cohort. Population-based controls could be sampled
from such platforms – which can be linked to census and
registry data [15] – thus providing ample information on a
whole range of relevant personal data, including biomark-
ers, disease histories and past exposures in order to unravel
the complexity of pathways and susceptibilities that under-
lie the NPP hypothesis [16, 17].
Last but not least, I agree with Kuehni and Spycher that
leukaemia should not be seen as a priority in the political
discussion about the future role of NPPs in energy policies.
NPPs come with societal challenges and risks far beyond
their possible link with leukaemia and, thus, need to be
judged in the broader context, including the fact that cata-
strophic accidents can occur and that the technology leaves
behind hazardous nuclear waste as a legacy for thousands
of generations to come.
In sum, future research on the biological, life-style, so-
ciocultural and environmental drivers of personal health
and disease will need a Swiss national mega-cohort with
its biobank. Switzerland has long-standing experience in
running highly successful cohorts. The time has come to
scale the national expertise up to a concerted Swiss national
mega-Cohort.
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